GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Indo Global Exchange(s) Pte Ltd (OTCPK:IGEX) » Definitions » Net Income

Indo Global Exchange(s) Pte (Indo Global Exchange(s) Pte) Net Income : $0.00 Mil (TTM As of Oct. 2017)


View and export this data going back to 2009. Start your Free Trial

What is Indo Global Exchange(s) Pte Net Income?

Net Income is the net profit that a company earns after deducting all costs and losses including cost of goods, SGA, DDA, interest expenses, non-recurring items and tax. Indo Global Exchange(s) Pte's Net Income for the three months ended in Oct. 2017 was $0.00 Mil. Its Net Income for the trailing twelve months (TTM) ended in Oct. 2017 was $0.00 Mil.

Net Income is linked to the most popular Earnings per Share (Diluted) number. Indo Global Exchange(s) Pte's Earnings per Share (Diluted) for the three months ended in Oct. 2017 was $0.00.


Indo Global Exchange(s) Pte Net Income Historical Data

The historical data trend for Indo Global Exchange(s) Pte's Net Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Indo Global Exchange(s) Pte Net Income Chart

Indo Global Exchange(s) Pte Annual Data
Trend Jul08 Jul09 Jul10 Jul11 Jul12 Jul13 Jul14 Jul15 Jul16 Jul17
Net Income
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.04 -0.43 -4.60 -2.45 -

Indo Global Exchange(s) Pte Quarterly Data
Jan13 Apr13 Jul13 Oct13 Jan14 Apr14 Jul14 Oct14 Jan15 Apr15 Jul15 Oct15 Jan16 Apr16 Jul16 Oct16 Jan17 Apr17 Jul17 Oct17
Net Income Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Indo Global Exchange(s) Pte Net Income Calculation

Net Income is the net profit that a company earns after deducting all costs and losses including cost of goods, SGA, DDA, interest expenses, non-recurring items and tax.

Net Income
= Revenue - Cost of Goods Sold - Selling, General, & Admin. Expense - Research & Development - Depreciation, Depletion and Amortization - Interest Expense - Non Operating Income (NRI) - Tax Expense + Others
= EBITDA - Depreciation, Depletion and Amortization - Interest Expense - Non Operating Income (NRI) - Tax Expense + Others
= Operating Income - Interest Expense - Non Operating Income (NRI) - Tax Expense + Others
= Pre-Tax Income - Tax Expense + Others

Indo Global Exchange(s) Pte's Net Income for the fiscal year that ended in Jul. 2017 is calculated as

Net Income(A: Jul. 2017 )
= Pre-Tax Income + Tax Provision + Net Income (Discontinued Operations) + Others
=0+0+0+0
=0.00

Indo Global Exchange(s) Pte's Net Income for the quarter that ended in Oct. 2017 is calculated as

Net Income(Q: Oct. 2017 )
= Pre-Tax Income + Tax Provision + Net Income (Discontinued Operations) + Others
=0+0+0+0
=0.00

Net Income for the trailing twelve months (TTM) ended in Oct. 2017 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Indo Global Exchange(s) Pte  (OTCPK:IGEX) Net Income Explanation

Net Income is the most widely cited number in reporting a company's profitability. It is linked to the most popular earnings-per-share (EPS) number through:

Indo Global Exchange(s) Pte's Earnings per Share (Diluted) (EPS) for the quarter that ended in Oct. 2017 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

EPS is most useful for companies that have:

A predictable business
Consistent accounting methods
And few restructurings

The dividend paid to preferred stocks needs to be subtracted from the total net income in the calculation of EPS because common stock holders are not entitled to that part of the net income.


Be Aware

Warren Buffett looks for consistency and upward long term trend. Because of share repurchase it is possible for net earnings trend to differ from EPS trend. He preferred Net Income over EPS. The companies with durable competitive advantage companies report higher % net earnings to total revenues.

Important: If a company is showing net earnings history greater than 20% on total revenues, it is probably benefiting from a long term competitive advantage.

If net earnings is less than 10%, likely to be in a highly competitive business.


Indo Global Exchange(s) Pte Net Income Related Terms

Thank you for viewing the detailed overview of Indo Global Exchange(s) Pte's Net Income provided by GuruFocus.com. Please click on the following links to see related term pages.


Indo Global Exchange(s) Pte (Indo Global Exchange(s) Pte) Business Description

Traded in Other Exchanges
N/A
Address
6400 S. Fiddlers Green, No. 250 No.1012, Greenwood Village, CO, USA, 80111
Indo Global Exchange(s) Pte Ltd is a holding company. The company is focusing on developing assets within the pharmaceutical and nutraceutical industries.